Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mesenchymal Stem Cell-Mediated Immunomodulation (MSC-Mediated Immunomodulation)
- Target
- MSC-Mediated Immunomodulation
- Molecular classification
- Cell Therapy, Immunomodulatory Agent
01
Overview
Mesenchymal stem cell (MSC)-mediated immunomodulation refers to the capacity of MSCs to regulate immune responses through the secretion of soluble factors (cytokines, chemokines, growth factors, prostaglandins, extracellular vesicles) and direct cell-to-cell contact. This results in the suppression of excessive inflammation or autoimmunity while promoting tissue repair. MSCs interact with various immune cells including T cells, B cells, dendritic cells, and macrophages, shifting them towards tolerogenic or anti-inflammatory phenotypes. MSCs are being investigated for the treatment of autoimmune diseases, graft-versus-host disease, inflammatory conditions, and tissue injuries.
- Other names
- MSC ImmunomodulationMesenchymal Stromal Cell ImmunomodulationMSC-Mediated Immune Regulation
02
Mechanism of action
Paracrine signaling via secreted factors (cytokines, chemokines, growth factors, prostaglandins, extracellular vesicles) and direct cell-to-cell contact leading to suppression of pro-inflammatory immune responses and promotion of tissue repair.
03
Biological functions
Immune response modulationInflammation regulationTissue repair promotionT cell suppressionB cell inhibitionDendritic cell modulationMacrophage polarization
04
Disease associations
Autoimmune diseasesGraft-versus-host disease (GvHD)Inflammatory conditionsTissue injuries
05
Safety considerations
Potential for ectopic tissue formationRisk of tumor promotionImmunogenicity (though generally low)Delivery method complicationsOff-target effectsBatch-to-batch variability in MSC potency
06
Interacting drugs
None (MSCs themselves are the therapeutic agent)
07
Biomarkers
Levels of secreted factors (IL-6, IL-10, TGF-β, PGE2)Treg cell populationPro-inflammatory cytokine levelsAnti-inflammatory cytokine levelsMSC homing and persistence
Beyond the preview
Go deeper on Mesenchymal Stem Cell-Mediated Immunomodulation (MSC-Mediated Immunomodulation).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mesenchymal Stem Cell-Mediated Immunomodulation (MSC-Mediated Immunomodulation).